David S Chang, MD
Plastic and Reconstructive Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 29 years
- New York University School of Medicine, 1997
Offices
1 location · Gabriel M Kind MD, Inc. · 3 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (415) 565-6884 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A68382 · Current
Licensed to practise in California · since 1999 · expires 2026-12-31 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Plastic Surgery - Plastic Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$60,280
Medicare paid this office $60,280 for 51 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Repair of wound by transferring skin, each additional 30.0 sq cm | 11 | $10,491 | $187 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 13 | $8,013 | $616 |
| New patient visit (30+ min) | 22 | $1,951 | $89 |
| Short return visit (20+ min) | 11 | $1,045 | $87 |
Procedures Medicare counted
| Mastectomy | 23 | More than 81% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Repair of wound by transferring skin, each additional 30.0 sq cm | – | – | – | – | – | 56 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | – | – | – | 12 | 16 | 13 |
| Breast reduction | – | – | – | – | 12 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
51 Original Medicare patients in 2024. Average age 70 · Health risk score 0.96. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: Cancer 71% · High blood pressure 53%.
The office billed $514,592, Medicare allowed $75,911 and paid $60,280; for 198 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 51 | 198 | 70 | 0.96 | $514,592 | $60,280 |
| 2023 | 54 | 178 | 69 | 1.05 | $338,501 | $56,280 |
| 2022 | 54 | 168 | 69 | 0.94 | $415,347 | $52,824 |
| 2021 | 62 | 184 | 69 | 0.93 | $381,803 | $61,910 |
| 2020 | 54 | 190 | 69 | 0.89 | $802,991 | $82,760 |
| 2019 | 56 | 193 | 69 | 1.01 | $476,983 | $65,225 |
| 2018 | 53 | 206 | 68 | 1.01 | $560,687 | $73,932 |
| 2017 | 41 | 165 | 65 | 0.96 | $344,464 | $58,809 |
| 2016 | 48 | 196 | 69 | 0.80 | $446,937 | $69,681 |
| 2015 | 49 | 175 | 67 | 0.86 | $291,189 | $61,810 |
| 2014 | 47 | 171 | 66 | 1.00 | $200,036 | $45,796 |
| 2013 | 66 | 254 | 67 | 1.02 | $294,107 | $62,600 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Breast reduction | 12 | $13,962 | $1,164 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 14 | $9,336 | $583 |
| New patient visit (30+ min) | 19 | $1,762 | $93 |
| Short return visit | 15 | $957 | $53 |
| New patient visit (15+ min) | 11 | $693 | $63 |
2022: 3 services
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 12 | $5,547 | $462 |
| New patient visit (30+ min) | 20 | $1,854 | $93 |
| Short return visit (20+ min) | 16 | $1,424 | $79 |
2021: 3 services
| New patient visit (60+ min) | 12 | $2,477 | $206 |
| New patient visit (30+ min) | 20 | $2,121 | $106 |
| Short return visit (20+ min) | 20 | $1,822 | $83 |
2020: 2 services
| New patient visit (30+ min) | 22 | $2,146 | $98 |
| Short return visit (20+ min) | 16 | $1,577 | $66 |
2019: 3 services
| New patient visit (30+ min) | 17 | $1,566 | $92 |
| Short return visit (20+ min) | 17 | $1,322 | $63 |
| Short return visit | 13 | $561 | $43 |
2018: 4 services
| New patient visit (60+ min) | 17 | $2,773 | $163 |
| Preparation of skin graft site of trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less | 13 | $2,721 | $181 |
| Short return visit (20+ min) | 15 | $1,105 | $65 |
| New patient visit (30+ min) | 12 | $1,048 | $87 |
2017: 2 services
| New patient visit (60+ min) | 16 | $2,746 | $172 |
| Short return visit | 11 | $588 | $35 |
2016: 2 services
| New patient visit (30+ min) | 13 | $1,191 | $92 |
| Short return visit (20+ min) | 11 | $995 | $66 |
2015: 3 services
| New patient visit (60+ min) | 17 | $3,053 | $180 |
| Short return visit (20+ min) | 13 | $943 | $63 |
| Short return visit | 12 | $553 | $33 |
2014: 3 services
| New patient visit (60+ min) | 11 | $1,856 | $169 |
| New patient visit (30+ min) | 11 | $1,116 | $101 |
| Short return visit | 14 | $858 | $39 |
2013: 4 services
| New patient visit (60+ min) | 16 | $2,930 | $183 |
| Short return visit (20+ min) | 22 | $1,953 | $67 |
| New patient visit (30+ min) | 17 | $1,658 | $98 |
| Short return visit | 14 | $941 | $41 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 46% of their 28 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 33 | 15 | None | None | $745 |
| 2022 | 16 | None | None | 0% | $238 |
| 2021 | 18 | 12 | None | None | $453 |
| 2020 | 28 | 14 | 46% (13) | None | $328 |
| 2019 | 29 | 13 | None | None | $284 |
| 2018 | 54 | 19 | 44% (24) | None | $589 |
| 2017 | 36 | 15 | None | None | $708 |
| 2016 | 105 | 34 | 11% (11) | 29% | $2,099 |
| 2015 | 33 | None | 36% (12) | None | $559 |
| 2014 | 26 | 15 | None | None | $437 |
| 2013 | 29 | 15 | None | None | $964 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Hydrocodone-Acetaminophen | 20 | $123 | $6 |
2016: 3 drugs
| Prednisolone Acetate | 20 | $794 | $40 |
| Diclofenac | 29 | $341 | $12 |
| Ciprofloxacin | 18 | $140 | $8 |
Money from drug and device companies
$1,752 in 2025
| 2025 | 5 | 7 | $1,200 | $1,752 |
| 2024 | 7 | 9 | $2,042 | $2,342 |
| 2023 | 4 | 17 | None | $595 |
| 2022 | 6 | 9 | $1,000 | $1,680 |
| 2021 | 5 | 11 | None | $467 |
| 2020 | 2 | 4 | None | $100 |
| 2019 | 11 | 24 | $6,430 | $9,550 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Rti Surgical | Cortiva Allograft Dermis | $1,365 | 2 payments
|
| Musculoskeletal Transplant Foundation | None | $170 | 1 payment
|
| Biocomposites | Stimulan | $145 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $58 | 2 payments
|
| Motiva USA | Motiva Implant Matrix | $14 | 1 payment
|
See all 7 published payments
| Musculoskeletal Transplant Foundation | Meals · 2025-09-10 | None | $170 |
| GlaxoSmithKline | Meals · 2025-08-28 | Trelegy Ellipta | $29 |
| Rti Surgical | Meals · 2025-07-09 | Cortiva Allograft Dermis | $165 |
| GlaxoSmithKline | Meals · 2025-07-03 | Trelegy Ellipta | $29 |
| Rti Surgical | Honoraria · 2025-07-03 | Cortiva Allograft Dermis | $1,200 |
| Motiva USA | Meals · 2025-05-06 | Motiva Implant Matrix | $14 |
| Biocomposites | Meals · 2025-03-20 | Stimulan | $145 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,342
| Urgo Medical North America | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap | $1,575 | 1 payment
|
| Becton Dickinson and | None | $467 | 1 payment
|
| Aroa Biosurgery | None | $139 | 1 payment
|
| Innovation Technologies | Irrisept | $87 | 3 payments
|
| Merck Sharp & Dohme | Keytruda | $33 | 1 payment
|
| Abbvie | Artia | $27 | 1 payment
|
| Motiva USA | Motiva Implant Matrix | $15 | 1 payment
|
2023: $595
| Musculoskeletal Transplant Foundation | None | $301 | 5 payments
|
| Rti Surgical | Fortiva Porcine Dermis | $149 | 1 payment
|
| Abbvie | Alloderm | $132 | 10 payments
|
| Innovation Technologies | Irrisept | $14 | 1 payment
|
2022: $1,680
| Rti Surgical | Cortiva Tailored Allograft | $1,000 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $468 | 3 payments
|
| Allergan | Natrelle Saline-Filled Breast Implants | $110 | 1 payment
|
| Integra LifeSciences | Integra | $65 | 2 payments
|
| Innovation Technologies | Irrisept | $19 | 1 payment
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $17 | 1 payment
|
2021: $467
| Integra LifeSciences | Amnioexcel | $198 | 7 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $155 | 1 payment
|
| Axogen | Avance Nerve Graft | $50 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $35 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Cosela | $29 | 1 payment
|
2020: $100
| Integra LifeSciences | Amnioexcel | $80 | 3 payments
|
| Endo Pharmaceuticals | Xiaflex | $20 | 1 payment
|
2019: $9,550
| RTI Surgical | Cortiva Allograft Dermis | $7,649 | 5 payments
|
| Apyx Medical | None | $788 | 4 payments
|
| Endo Pharmaceuticals | Xiaflex | $191 | 3 payments
|
| Medela | None | $191 | 2 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $182 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $174 | 1 payment
|
| Derma Sciences | Amnioexcel | $143 | 2 payments
|
| TEI Biosciences | Surgimend | $132 | 1 payment
|
| Axogen | Axoguard Nerve Connector | $52 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $24 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Vitrakvi | $23 | 1 payment
|
Professional record
- NPI
- 1629093208
- Licence
- CA A68382California A68382: Current · expires 2026-12-31
- Trained
- New York University School of Medicine, 1997 · 29 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- Po Box 7464, San Francisco, CA, 94120
- NPI first listed
- 2006-07-13
- NPI last updated
- 2022-01-13
- NPI record certified
- 2022-01-13
This is when the NPI record was last certified, not a medical board exam.